-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cytek Biosciences, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2023.
- Cytek Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$4.39M, a 525% decline year-over-year.
- Cytek Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$5.85M, a 125% decline year-over-year.
- Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.1M, a 589% decline from 2022.
- Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $2.48M, a 17.9% decline from 2021.
- Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $3.03M, a 84.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)